SHANGHAI HILE BIO-TECHNOLOGY financial statements, including revenue, expenses, profit, and loss
The total revenue of 603718 for the last quarter is 65.83 M CNY, and it's 17.79% higher compared to the previous quarter. The net income of Q3 23 is 30.02 M CNY.